OptimizeRx Co. (NASDAQ:OPRX) Receives Consensus Recommendati

OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the seven analysts that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price target among analysts that […]

Related Keywords

Hong Kong , Canada , Stifel Nicolaus , Nisa Investment Advisors , Royal Bank , Optimizerx Corporation , Nasdaq , Optimizerx Company Profile , Optimizerx Co , Barclays , Hong Kong Ltd , Get Free Report , Investment Advisors , Financial Advisors , Kong Ltd , Get Free , Evidence Based Physician Engagement , Care Banner , Optimizerx Daily , Optimizerx , Nasdaq Oprx , Oprx , Computer And Technology , Ratings , Consensus ,